Quick Answer
AYTU BIOPHARMA, INC reported Long-Term Debt of $10.88 million for fiscal year 2024.
AYTU BIOPHARMA, INC Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2024 | $10.88M | -26.1% |
| 2023 | $14.71M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| December 31, 2024 | $9.98M | -33.3% | -4.3% |
| September 30, 2024 | $10.43M | — | -4.1% |
| June 30, 2024 | $10.88M | -26.1% | — |
| March 31, 2024 | $0.00 | — | -100.0% |
| December 31, 2023 | $14.98M | — | +1.8% |
| June 30, 2023 | $14.71M | — | +80.3% |
| March 31, 2020 | $8.16M | +59.0% | -65.1% |
| December 31, 2019 | $23.39M | +364.5% | — |
- AYTU BIOPHARMA, INC showed a decrease of -26.1% in Long-Term Debt compared to the prior fiscal year.
- Over the 2023–2024 period, AYTU BIOPHARMA, INC’s long-term debt has declined by 26.1% (from $14.71 million to $10.88 million).
- The most recent figure is from AYTU BIOPHARMA, INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on September 26, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: